12-Lipoxygenax oxygenates the 12 position of arachidonic acid, produciag its I2S-hydtoperoxg derivative. We have been interested in the distribution of 12-lipxygenase in the central nervous system. Previously, by the use of a monoclonal anti-12-lipxygenase antibody, we proved that one of the arachidonate 12-lipoxygenases existed in canine brain. The ptesent study was therefore designed to elucidate the exact immunohistochemical localization of arachidonate 12-lipoxygenase in canine brain, using a plyclonal anti-12-lipoxygenase antibody. Canine brains were irrigated thoroughly with ice-cold heparinized saline and phosphate-buEed saline to remove blood cells, and then were fixed in 4% perio-
Introduction
Lipoxygenases are the enzymes that oxygenate arachidonic acid and other polyunsaturated fatty acids, producing hydroperoxy derivatives. Arachidonate 12-lipoxygenase of human platelets was the first lipoxygenase discovered in mammalian tissues (8). Sautebin et al. (20) reported that 12-hydroxy-1,8,14-cz~-lO-~~~~~-eicosatetraenoic acid (12-HETE) was formed in the gerbil brain and that its synthesis was increased in ischemia. This may be the first reported evidence of the occurrence of lipoxygenase metabolites in the central nervous system. It was later reported that 12-HETE was the principal lipoxygenase product in the brain (21JO). Arachidonate 12lipoxygenase itself has also been found in various mammalian tissues. However, it is not obvious how 12-lipoxygenase metabolites of arachidonic acid act as biological mediators. suggested that arachidonic acid and some of its 12-lipoxygenase metabolites played a role as second messengers in synaptic transmission. Furthermore, it was proposed that arachidonic acid and its 12-lipoxygenase metabolites might function as retrograde messengers in hippocampal long-term potentiation (LTP) ( datc+lysine-parafounaldehyde at 4'C for 3 hr. Immunostaining by the indirect method with the peroxidase-labeled antibody was performed for light microscopic observation. The immunohistochemical study demonstrated that many neurons and glial cells in the cerebrum, basal ganglia, and hippocampus were positively stained. Biochemical results as described previously and those of immunohistochemistry indicate that 12-lipoxygenase is definitely localized in various brain parenchymal cells. (J Histochem C j " 41: [111] [112] [113] [114] [115] [116] [117] 1993) prove the relevance or validity of these notions, elucidation of the exact tissue and cellular localization of the enzyme in the brain appears essential or at least useful. However, the localization or generating site of arachidonate 12-lipoxygenase remains essentially undetermined.
The present study was therefore aimed at elucidation of the precise localizations of 12-lipoxygenase in various tissues and cells of canine brain by using a polyclonal antibody against 12-lipoxygenase of porcine leukocytes prepared previously in our laboratory (13).
Materials and Methods
Materials. Periodic acid, lysine, and Twctn-20 wen purchased from Wako Pure Chemical Industries (Osaka, Japan), high molecular weight standard mixture for sodium dodccyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) from Pharmacia (Uppsala, Sweden), nitrocellulose membrane from Schleicher & Schuell (Dasscl, Germany), paraformaldehyde from Merck (Darmstadt, Germany), 3,3'-diaminobentidine (DAB) from Dojin (Kumamoto. Japan), horseradish peroxidase from Toyobo (Osaka, Japan), OCT compound from Miles Laboratories (Naperville, E), MGK from Matsunami (Osaka, Japan), methyl green from Chroma-Gesellschaft (Korgcn, Germany), Affi-Prep 10 from Bio-Rad Laboratories (Richmond, CA), and mouse monoclonal anti-human glial fibrillary acidic protein (GFAP) antibody from h e rsham International (Poole, UK).
Preparation of Canine Brains. Ten adult mongrel dogs weighing 7-13 112 NISHIYAMA. WATANABE, UEDA, TSUKAMOTO, WATANABE kg were deeply anesthetized by IV injection of pentobarbital (30 mglkg). After endotracheal intubation, the head was placed in a stereotaxic frame in the supine position. Bilateral vertebral arteries and common carotid arteries were exposed and cannulated. Each animal was exsanguinated, and the brain was successively perfused with 1 liter of ice-cold saline containing heparin (10 Ulml) and the same amount of ice-cold PBS, pH 7.4, via the vertebral and common carotid arteries to wash out blood cells.
The dogs were cared for in compliance with the standards relating to the care and the management of experimental animals recommended by the Japanese Prime Minister's Office and the Japan Animal Welfare Society.
Preparation of Antibodies. A monoclonal antibody (lox-2) (22) and a polyclonal antibody (13) against porcine leukocyte 12-lipoxygenase, which crossreacted with canine 12-lipoxygenase, were prepared. Arachidonate 12lipoxygenase was purified from the cytosol fraction of porcine leukocytes. using the monoclonal antibody as described previously (31) . Immundnitypurification of the polyclonal anti-12-lipoxygenase antibody was performed as follows. The antibody (1 ml) was applied to the Affi-Prep 10 column (10 x 25 mm) to which immunoaffinity-purified porcine leukocyte 12lipoxygenase was conjugated. The pass-through fraction that did not react with purified 12-lipoxygcnasc was used as the absorbed antibody. After the column was washed with 7 ml of PBS, pH 7.4, the anti-12-lipoxygenase antibody was eluted with 0.1 M glycine-HCI buffer (pH 2.2). Protein concentrations were determined by the method of Lowry et al. (11) . with bovine serum albumin (BSA) as a standard.
Immunoblotting. Canine brains were additionally perfused with 500 ml of ice-cold 20 mM Xis-HCI buffer (pH 7.4) containing 1 mM EDTA and 1 mM dithiothreitol. The irrigated canine cerebrum was homogenized in 5 volumes of the same buffer by use of a Potter-Elvehjem homogenizer. The homogenate was centrifuged at 27.000 x g for 10 min and then at 105,000 x g for 60 min at 4°C. The supernatant solution was stored at -8O'C as the cytosol fraction.
The cytosol fraction of canine cerebrum (160 pg of protein) and the purified porcine leukocyte 12-lipoxygenase (0.4 pg of protein) were subjected to 7.5% SDS-PAGE according to the method of Laemmli. Then protein bands were transferred from the gel to a nitrocellulose membrane by the method of Tmbin et al. (25) . 12-Lipoxygenase on the nitrocellulose membrane was immunostained with polyclonal anti-12-lipoxygenase antibody (ammonium sulfate precipitate, 22 pglml) or non-immunized rabbit IgG (22 pglml) with the fragment of goat anti-rabbit IgG labeled with horseradish peroxidase (3.4 pglml) and DAB as described previously (13).
The crossreactivity of monoclonal anti-human GFAP antibody against canine cerebral GFAP was also examined in the same manner as described above.
Immunostaining for Light Microscopy. Canine brains were irrigated with 300 ml of ice-cold 4% periodate-lysine-paraformaldehyde (PLP), removed, and cut into small pieces ( 5 x 5 x 3 mm). Then small specimens were immersed and fixed in PLP solution at 4'C for 3 hr. washed successively with cold PBS (pH 7.4) containing 10, 15. and 20% sucrose. and embedded in OCT compound. Frozen sections (8 pm thick) were prepared with a cryostat and air-dried on ovalbumin-coated glass slides. Endogenous peroxidase activity was inhibited by incubation with 0.3% hydrogen peroxide in methanol for 30 min at room temperature. Immunostaining was performed by the indirect method of Nakane et al. (14) as described previously (13). The polyclonal anti-12-lipoxygenase antibody (ammonium sulfate precipitate or immunoaffinity-purified IgG. 20 pglml) and peroxidaselabeled F(ab) fragment of goat anti-rabbit IgG (3.4 pglml) were used as the first and second antibodies. respectively. As control for the immunoperoxidax method. the sections were reacted with immunoaffinity-absorbed antibody (IgG, 20 pglml) as the fm antibody instead of the anti-12-lipoxygenax rabbit IgG. The peroxidase reaction was performed at room temperature for 5 min in 50 mM Tris-HCI buffer (pH 7.6) containing hydrogen peroxide as the substrate and DAB as the hydrogen donor. The specimens were counterstained with 5% methyl green.
For identifying glial cells, GFAP was immunostained in the same manner, with monoclonal anti-human GFAP antibody and peroxidase-labeled F(ab) fragment of goat anti-mouse IgG as the first and second antibodies, respectively.
Microscopic observation and subsequent photography were usually done with an Axiophot (Carl Zeiss; Oberkochen, Germany). In some cases. when the immunostaining was so weak that the cell contour was barely apparent by ordinary light microscopy (astrocytes in white matter). the images obtained with the Axiophot were input into IBAS (Interactive Build Analysis System) (Carl &is) to enhance the image contrast through contrast normalization (9) and then photographed. The control sections that were reacted with the immunoaffinity-absorbed antibody were also similarly photographed.
Immunoblotting
The immunospecificity of the polyclonal antibody, which was raised against porcine leukocyte 12-lipoxygenase, was ensured by the immunoblotting technique. The cytosol fraction of canine cerebrum showed a single major band at the position corresponding to 68 KD molecular weight ( Figure 1A) . The immunoaffinity-purified 12-lipoxygenase also showed the same band ( Figure 1B) . No significant band was detected with the non-immunized rabbit IgG.
The immunospecificity of monoclonal anti-human GFAP antibody was also checked in the same way. This monoclonal antibody crossreacted in a single band with the canine cerebral cytosol. 
W

Im munostaining
By light microscopy, many neurons in the cerebral cortex (Figures  2A and 2B) and glial cells in the gray (Figure 2A ) and white matter ( Figure 2C) were positively immunostained. The immunostaining of glial cells was slightly weaker than that of neurons, and those images of glial cells were processed by IBAS (see Materials and Methods). The image contrast was efficiently enhanced by this processing without any interference of background staining ( Figure  2C ). With this image processing (intensification), it was confirmed that the extended processes of glial cells (astrocyte) are attached to the capillary wall ( Figure 2C ). No stained cells were found in a control experiment with the immunoabsorbed antibody ( Figure  2D ) even though the images were processed by IBAS ( Figure 2D , inset).
The pyramidal cells and the granule cells in the hippocampus (Figures 3A-3D) . neurons in the striatum, and olivary nucleus were positively stained for 12-1ipoXYgenase.
To identdy glial cells, the same specimen was also immunostained with the monoclonal anti-human GFAP antibody. Glial cells of the canine brain were specifically positive. Smaller cells that were posi- tively immunostained with the polyclonal anti-12-lipoxygenase antibody were identified morphologically as glial cells ( Figure 2C) . Endothelial cells were also positively immunostained (Figure 4A ).
Discussion
Immunohistochemical Localization of 12-Lipoxygenase in Canine Brain
This study demonstrated immunohistochemically that 12-lipoxygenase exists in neurons, glial cells, and endothelial cells of canine brain. Polyclonal anti-porcine 12-lipoxygenase antibody, which was proven to crossreact with canine leukocyte 12-lipoxygenase in our laboratory. was used for the immunostaining.
The cytoplasm of those cells in the canine brains was diffusely stained to indicate the cytosolic localization of the enzyme (Figures  2 and 3) . This was substantiated by our biochemical study (15). The 12-lipoxygenase was proven to be a cytosolic protein by both immunoelectron microscopic and biochemical examinations done on various porcine tissues and cells such as neutrophils, monocytes and resident mast cells in lymph nodes, spleen, thymus, alimentary tract, ovary and lung, and parenchymal cells of anterior pituitary gland (13.26). Under ordinary light microscopic observation, the processes of glial cells (astrocytes) were generally so weakly stained that they could hardly be identified. However, the introduction of the computer imaging technique (9). which can strengthen the weakly stained images effectively, enabled us to confirm the fine spatial relationship between the processes of glial cells and microvessels ( Figure 2C) . The specificity and validity of the immunostaining shown here were confirmed by both the control immunostain-ing with immunoaffinity-absorbed antibody and immunoblotting tests.
Biological Signz9cance of 12-Lipoxygenase in Canine Brain
There are some reports on the participation of either arachidonic acid or its 1Nipoxygenase metabolites in the induction of hippocampal long-term potentiation (LTP) as retrograde messengers (5,6, [27] [28] [29] . Which lipid plays the more essential role in the induction of LTP among arachidonic acid and its 12-lipoxygenase metabolites, however, is still controversial. Barbour et al. (2) stressed that arachidonic acid itself was the key substance. They reported that arachidonic acid inhibited glutamate uptake into the glial cells, and that blockade of phospholipase A2 prevented the induction of LV, whereas cyclooxygenase or lipoxygenase inhibitors had no effects on the action of arachidonic acid. In the present experiments, however, pyramidal cells and granule cells in canine hippocampus (Figures 3A-3D ) and the glial cells (Figures 2A and 2C) were proven to contain 12-lipoxygenase. The immunoaffinity-purified enzyme of canine cerebrum had a specific activity of 9 nmollminlmg of protein, which might be enough enzyme activity to produce physiological action (15). For further confirmation of the possibility that 12-lipoxygenase metabolites of arachidonic acid are acting as the physiological mediators, the time-sequential changes of the activity and the precise intracellular distribution (presynaptic or postsynaptic) of the enzyme (12-lipoxygenase) at each phase of ITP must be clarified.
Since Demopoulos (4) reported the involvement of oxygen radical metabolites of lipids in cerebral ischemia, several studies on the participation of lipid peroxides, especially eicosanoids, in the pathogenesis of brain ischemia have been reported (3,7,32). The possible dysfunction of Na+,K*-ATPase in the pathogenesis of postischemic brain edema has been well documented (1,10,12,24). A 10-nmol to 10 pmol level of ~5-hydroperoxy-~,8,1l-cis-13-t~anreicosatetraenoic acid was found to enhance ATPase activity in rat cerebral microvessels, and this effect was suppressed by eicosatetraynoic acid and caffeic acid (nonspecific lipoxygenase inhibitors) but not by indomethacin (10). This suggests the possible participation of lipoxygenases in post-ischemic brain edema. Astroglial swelling has been well documented in the first stage of brain edema associated with ischemia (16.2 3). The significance of arachidonate 12-lipoxygenase in endothelial cells and glial cells during brain ischemia must be further investigated.
In addition to the biochemical and immunochemical determination of 12-lipoxygenase in canine brains, the distribution of 12lipoxygenase positive cells in the brains was elucidated in the present study. These results should provide important information for understanding the roles of the enzyme in brain under physiological and pathological conditions. For further confirmation of the validity of arachidonate 12-lipoxygenase localization in the parenchymal cells of the brain, isolation of cDNA encoding this enzyme protein is now under investigation.
